semaglutide compounding lawsuit news Troubling Findings in Study of GLP-1 Compounders FDA sued over 'reckless and

Recommended corrective actions could include identifying the facilities compounding the GLP-1 products, providing sample product labeling and revising or removing the misleading claims cited on its platform

Wegovy may cause serious side effects, including: inflammation of your pancreas (pancreatitis)

Patients are encouraged to report any unexpected side effects from either treatment to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk), which plays a vital role in post-market safety surveillance and helps build the evidence base for emerging therapies such as retatrutide

Packer M et al., SUMMIT, NEJM 2024 (NEJMoa2410027, PMID 39555826) : tirzepatide and HFpEF with obesity, HR 0,62 composite endpoint

Mann, E

Through her own personal story, Oprah invites us into a dialogue that transcends the conventional, highlighting groundbreaking medications like Ozempic, Mounjaro, and Wegovy, and the broader implications of access to such treatments